ArticleSleep2026
Hypothalamic volume reduction in adult patients with narcolepsy type 1.
Article in Sleep, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
STUDY
objectivesNarcolepsy-type 1 (NT1) is a neurological sleep disorder, characterized by a loss of orexin-producing cells in the posterior hypothalamus. These neurons are approximately 70 000 but have large orexin-containing projections within the hypothalamus and other brain areas. Several evidences suggest an autoimmune origin, while pathological studies in postmortem samples collected decades after onset have found variable gliosis. In this study, we studied MRI-based volumes in the hypothalamus in a large cohort of patients with NT1 versus healthy controls.
methodsA consecutive cohort of 75 adult NT1 patients (36 females 33.1 ± 12.8 years old) and 85 age- and sex-matched healthy controls (42 females, 32.5 ± 8.2 years old) underwent neuroimaging, including T1-weighted MPRAGE MRI at 3Tesla. The hypothalamus and its subregions (anterior-inferior, anterior-superior, posterior, tuberal-inferior, and tuberal-superior) were segmented from T1 images using an automated tool. Hypothalamic volumes were compared between groups and correlated with clinical features and orexin levels in the cerebrospinal fluid.
resultsAdjusted for whole brain-volume, patients showed reductions in hypothalamic volume compared to healthy controls (p=.01). These reductions were found across most hypothalamic subregions, anterior-inferior (p<.001), anterior-superior (p=.003), posterior (p=.03), and tuberal-superior (p=.04), but not in the tuberal-inferior subregion. No significant correlations were found with clinical or laboratory variables.
conclusionsAutomated volumetric analysis of brain MRI showed hypothalamic atrophy in NT1 patients compared to healthy controls. Future pathological studies are needed to address the diagnostic and mechanistic relevance of this finding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.